Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-Year study reveals how doctors treat rare coronary artery bulges

NCT ID NCT07211854

Knowledge-focused Sponsor: Franck Assayag Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked back at 51 patients with widened or bulging coronary arteries to see which blood-thinning medications they were prescribed and how those treatments affected their risk of heart attacks, strokes, or bleeding. Researchers reviewed records from a single hospital over 10 years. The goal was to understand real-world prescribing patterns and their outcomes, not to test a new drug.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors choose safer and more effective blood-thinning treatments for people with widened or bulging coronary arteries.
What could go wrong
This is a small, single-center observational study, not a controlled trial. It can show associations but cannot prove which treatment is best. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

51 people

The number who actually took part.

Started

Sep 2024

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

A patient with aneurysmal or ectatic coronary disease with bi- or tri-truncular involvement on coronary angiography.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient \> 18 years old * Patient living or deceased * Patient with aneurysmal or ectatic coronary artery disease with bi- or tri-truncular involvement at coronary angiography. Exclusion Criteria: * Patient \< 18 years old * Monotruncal aneurysmal or ectatic disease * Absence of coronary aneurysm / ectasia * Patient's opposition to participation in research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery dilatations and aneursyms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery dilatations and aneursyms

Contacts and locations

Locations

  • Centre Hospitalier de Versailles

    Le Chesnay, 78150, France